ALGS logo

Aligos Therapeutics (ALGS) CAPEX

Annual CAPEX

$130.00 K
+$111.00 K+584.21%

December 31, 2024


Summary


Performance

ALGS CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALGScash flowmetrics:

Quarterly CAPEX

$28.00 K
+$2000.00+7.69%

December 1, 2024


Summary


Performance

ALGS Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALGScash flowmetrics:

TTM CAPEX

$130.00 K
+$21.00 K+19.27%

December 1, 2024


Summary


Performance

ALGS TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALGScash flowmetrics:

ALGS CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+584.2%+7.7%+19.3%
3 y3 years-85.4%+300.0%-70.1%
5 y5 years-+300.0%-70.1%

ALGS CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-86.2%+584.2%-94.6%+500.0%-89.9%+584.2%
5 y5-year-86.2%+584.2%-94.6%+500.0%-89.9%+584.2%
alltimeall time-86.2%+584.2%-94.6%+500.0%-89.9%+584.2%

Aligos Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Dec 2024
$130.00 K(+584.2%)
-
-
Dec 2024
-
$28.00 K(+7.7%)
$130.00 K(+19.3%)
Sep 2024
-
$26.00 K(+271.4%)
$109.00 K(+14.7%)
Jun 2024
-
$7000.00(-89.9%)
$95.00 K(+17.3%)
Mar 2024
-
$69.00 K(+885.7%)
$81.00 K(+326.3%)
Dec 2023
$19.00 K
$7000.00(-41.7%)
$19.00 K(-81.6%)
Sep 2023
-
$12.00 K(-271.4%)
$103.00 K(+9.6%)
Jun 2023
-
-$7000.00(-200.0%)
$94.00 K(-78.4%)
DateAnnualQuarterlyTTM
Mar 2023
-
$7000.00(-92.3%)
$435.00 K(-53.9%)
Dec 2022
$943.00 K(+5.7%)
$91.00 K(+2933.3%)
$943.00 K(-20.6%)
Sep 2022
-
$3000.00(-99.1%)
$1.19 M(-7.3%)
Jun 2022
-
$334.00 K(-35.1%)
$1.28 M(+16.5%)
Mar 2022
-
$515.00 K(+53.3%)
$1.10 M(+23.3%)
Dec 2021
$892.00 K
$336.00 K(+246.4%)
$892.00 K(+60.4%)
Sep 2021
-
$97.00 K(-36.2%)
$556.00 K(+21.1%)
Jun 2021
-
$152.00 K(-50.5%)
$459.00 K(+49.5%)
Mar 2021
-
$307.00 K
$307.00 K

FAQ

  • What is Aligos Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Aligos Therapeutics?
  • What is Aligos Therapeutics annual CAPEX year-on-year change?
  • What is Aligos Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Aligos Therapeutics?
  • What is Aligos Therapeutics quarterly CAPEX year-on-year change?
  • What is Aligos Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Aligos Therapeutics?
  • What is Aligos Therapeutics TTM CAPEX year-on-year change?

What is Aligos Therapeutics annual capital expenditures?

The current annual CAPEX of ALGS is $130.00 K

What is the all time high annual CAPEX for Aligos Therapeutics?

Aligos Therapeutics all-time high annual capital expenditures is $943.00 K

What is Aligos Therapeutics annual CAPEX year-on-year change?

Over the past year, ALGS annual capital expenditures has changed by +$111.00 K (+584.21%)

What is Aligos Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of ALGS is $28.00 K

What is the all time high quarterly CAPEX for Aligos Therapeutics?

Aligos Therapeutics all-time high quarterly capital expenditures is $515.00 K

What is Aligos Therapeutics quarterly CAPEX year-on-year change?

Over the past year, ALGS quarterly capital expenditures has changed by +$2000.00 (+7.69%)

What is Aligos Therapeutics TTM capital expenditures?

The current TTM CAPEX of ALGS is $130.00 K

What is the all time high TTM CAPEX for Aligos Therapeutics?

Aligos Therapeutics all-time high TTM capital expenditures is $1.28 M

What is Aligos Therapeutics TTM CAPEX year-on-year change?

Over the past year, ALGS TTM capital expenditures has changed by +$21.00 K (+19.27%)